C07K 9/00
Peptides having up to 20 amino acids, containing saccharide radicals and having
Official title: Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
C07K9/00 (Peptides having up to 20 amino acids, containing saccharide radicals and having) appears on 808 US grants and 686 published applications in this corpus.
Search patents in C07K- Granted patents
- 808
- Published applications
- 686
- Assignees
- 461
- Inventors
- 1,844
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 4 | 0 |
| 1982 | 14 | 0 |
| 1983 | 17 | 0 |
| 1984 | 14 | 0 |
| 1985 | 25 | 0 |
| 1986 | 12 | 0 |
| 1987 | 28 | 0 |
| 1988 | 11 | 0 |
| 1989 | 15 | 0 |
| 1990 | 16 | 0 |
| 1991 | 12 | 0 |
| 1992 | 8 | 0 |
| 1993 | 15 | 0 |
| 1994 | 10 | 0 |
| 1995 | 10 | 0 |
| 1996 | 15 | 0 |
| 1997 | 23 | 0 |
| 1998 | 19 | 0 |
| 1999 | 24 | 0 |
| 2000 | 15 | 0 |
| 2001 | 8 | 1 |
| 2002 | 20 | 15 |
| 2003 | 18 | 35 |
| 2004 | 14 | 36 |
| 2005 | 20 | 42 |
| 2006 | 29 | 41 |
| 2007 | 27 | 30 |
| 2008 | 25 | 43 |
| 2009 | 17 | 36 |
| 2010 | 26 | 34 |
| 2011 | 20 | 26 |
| 2012 | 24 | 26 |
| 2013 | 16 | 21 |
| 2014 | 26 | 38 |
| 2015 | 34 | 24 |
| 2016 | 15 | 35 |
| 2017 | 13 | 27 |
| 2018 | 19 | 26 |
| 2019 | 20 | 23 |
| 2020 | 19 | 22 |
| 2021 | 20 | 26 |
| 2022 | 14 | 16 |
| 2023 | 12 | 21 |
| 2024 | 10 | 13 |
| 2025 | 9 | 21 |
| 2026 | 3 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and uses of enzymatic labeling of ADP-ribose containing molecules14 Apr 2026US 12,601,734 B2Cold Spring Harbor Laboratory
- Cell penetrating peptides24 Mar 2026US 12,583,889 B2Oxford University Innovation Limited
- Glycopeptide antibiotic combination therapy27 Jan 2026US 12,533,389 B2Emory University
- Ang (1-7) derivative oligopeptides for the treatment of pain7 Oct 2025US 12,433,932 B2Arizona Board of Regents on Behalf of the University of Arizona
- Cyclic compound having selective KRAS inhibitory effect on HRAS and NRAS9 Sep 2025US 12,410,212 B2Chugai Seiyaku Kabushiki Kaisha
- Improving microbial activity17 Sep 2026US 2026/0275269 A1BASF SE
- Antibiotic Vancomycin-Teixobactin Conjugates10 Sep 2026US 2026/0263611 A1The Regents of the University of California
- Occidiofungin analogs and methods of making and using13 Aug 2026US 2026/0234194 A1Sano Chemicals
- Synthetic glycopeptides and derivatives for the early-stage detection of cancer biomarkers in muc1-positive tumors6 Aug 2026US 2026/0227407 A1
- Cell penetrating peptides2 Jul 2026US 2026/0184743 A1Oxford University Innovation Limited
Most cited
By later US patents
- PNA-DNA-PNA chimeric macromolecules416US 5,700,922 AIsis Pharmaceuticals, Inc. · 1997
- Library of glyco-peptides useful for identification of cell adhesion inhibitors156US 5,795,958 AGlycomed Incorporated · 1998
- Redox reversible bipyridyl-osmium complex conjugates126US 7,045,310 B2Roche Diagnostics Operations, Inc. · 2006
- Method and device for electrochemical immunoassay of multiple analytes102US 6,294,062 B1Roche Diagnostics GmbH · 2001
- Novel glycopeptide derivatives99US 4,698,327 AEli Lilly and Company · 1987